Kristin Artinger

Prof. Dr. Kristin Artinger

Department of Craniofacial Biology, School of Dental Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2009 in Developmental Biology
Verified
Journal Article
Closed access
EKEugenia C. Olesnicky Killian
Eugenia C. Olesnicky Killian
DBDenise A. Birkholz
Denise A. Birkholz
Kristin ArtingerKristin Artinger
Kristin Artinger

1 May 2020 in Developmental Biology
Verified
Journal Article
Closed access
LSLomeli Carpio Shull
Lomeli Carpio Shull
Rwik SenRwik Sen
Rwik Sen
JMJohannes Menzel
Johannes Menzel
SGSusumu Goyama
Susumu Goyama
MKMineo Kurokawa
Mineo Kurokawa
Kristin ArtingerKristin Artinger
Kristin Artinger

1 July 2016 in Developmental Biology
Verified
Journal Article
Closed access
EOEric Van Otterloo
Eric Van Otterloo
TWTrevor Williams
Trevor Williams
Kristin ArtingerKristin Artinger
Kristin Artinger

10 April 2013 in WIREs Mechanisms of Disease
Verified
Journal Article
Open access
PDF file
DPDavalyn R. Powell
Davalyn R. Powell
ABAlex J. Blasky
Alex J. Blasky
SBSteven G. Britt
Steven G. Britt
Kristin ArtingerKristin Artinger
Kristin Artinger
The neural crest (NC) is first induced as an epithelial population of cells at the neural plate border requiring complex signaling between bone morphogenetic protein, Wnt, and fibroblast growth factors to differentiate the neural and NC fate from the epidermis. Remarkably, following induction, these cells undergo an epithelial‐to‐mesenchymal transition (EMT), delaminate from the neural tube, and migrate through various tissue types and microenvironments before reaching their final destination where they undergo terminal differentiation. This process is mirrored in cancer metastasis, where a primary tumor will undergo an EMT before migrating and invading other cell populations to create a secondary tumor site. In recent years, as our understanding of NC EMT and migration has deepened, important new insights into tumorigenesis and metastasis have also been achieved. These discoveries have been driven by the observation that many cancers misregulate developmental genes to reacquire proliferative and migratory states. In this review, we examine how the NC provides an excellent model for studying EMT and migration. These data are discussed from the perspective of the gene regulatory networks that control both NC and cancer cell EMT and migration. Deciphering these processes in a comparative manner will expand our knowledge of the underlying etiology and pathogenesis of cancer and promote the development of novel targeted therapeutic strategies for cancer patients. WIREs Syst Biol Med 2013, 5:511–522. doi: 10.1002/wsbm.1224This article is categorized under: Biological Mechanisms > Cell Fates Biological Mechanisms > Cell Signaling Developmental Biology > Developmental Processes in Health and Disease

15 August 2013 in Development
Verified
Journal Article
Closed access
PDF file
DPDavalyn R. Powell
Davalyn R. Powell
LHLaura Hernandez-Lagunas
Laura Hernandez-Lagunas
KLKristi LaMonica
Kristi LaMonica
Kristin ArtingerKristin Artinger
Kristin Artinger
The neural crest comprises multipotent precursor cells that are induced at the neural plate border by a series of complex signaling and genetic interactions. Several transcription factors, termed neural crest specifiers, are necessary for early neural crest development; however, the nature of their interactions and regulation is not well understood. Here, we have established that the PR/SET domain-containing transcription factor Prdm1a is co-expressed with two essential neural crest specifiers, foxd3 and tfap2a, at the neural plate border. Through rescue experiments, chromatin immunoprecipitation and reporter assays, we have determined that Prdm1a directly binds to and transcriptionally activates enhancers for foxd3 and tfap2a and that they are functional, direct targets of Prdm1a at the neural plate border. Additionally, analysis of dominant activator and dominant repressor Prdm1a constructs suggests that Prdm1a is required both as a transcriptional activator and transcriptional repressor for neural crest development in zebrafish embryos.

26 October 2012 in Developmental Dynamics
Verified
Journal Article
Open access
PDF file
HDHai‐Lei Ding
Hai‐Lei Ding
DCDavid E. Clouthier
David E. Clouthier
Kristin ArtingerKristin Artinger
Kristin Artinger
Background: PRDM proteins are evolutionary conserved Zn‐Finger transcription factors that share a characteristic protein domain organization. Previous studies have shown that prdm1a is required for the specification and differentiation of neural crest cells in the zebrafish. Results: Here we examine other members of this family, specifically prdm3, 5, and 16, in the differentiation of the zebrafish craniofacial skeleton. prdm3 and prdm16 are strongly expressed in the pharyngeal arches, while prdm5 is expressed specifically in the area of the forming neurocranium. Knockdown of prdm3 and prdm16 results in a reduction in the neural crest markers dlx2a and barx1 and defects in both the viscerocranium and the neurocranium. The knockdown of prdm3 and prdm16 in combination is additive in the neurocranium, but not in the viscerocranium. Injection of sub‐optimal doses of prdm1a with prdm3 or prdm16 Morpholinos together leads to more severe phenotypes in the viscerocranium and neurocranium. prdm5 mutants have defects in the neurocranium and prdm1a and prdm5 double mutants also show more severe phenotypes. Conclusions: Overall, our data reveal that prdm3, 5, and 16 are involved in the zebrafish craniofacial development and that prdm1a may interact with prdm3, 5, and 16 in the formation of the craniofacial skeleton in zebrafish. Developmental Dynamics 242:67–79, 2013.